Her research investigates the genomic alterations resulting from chronic nicotine administration and withdrawal using Next Next-Gen sequencing and how these changes impact both behavior and concordant transcriptionally-driven circuitry adaptations. These altered preclinical genomic targets serve as candidates for SNP analysis in the smoking population. Dr. Turner earned her PhD with Dr. Ken Kellar at Georgetown University and completed post-doctoral training with Dr. Julie Blendy at the Center for Interdisciplinary Research on Nicotine Addiction (CIRNA), University of Pennsylvania.